Search research articles
Contact Us
Filters
Showing results (381-390 of 471) with videos related to
Page
of 48
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
September 18, 2023
A phase I/II study of the safety and efficacy of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours
Damian Wild, Henning Grønbæk, Shaunak Navalkissoor, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 17, 2020
Peptide Receptor Radionuclide Therapy with <sup>67</sup>Cu-CuSarTATE Is Highly Efficacious Against a Somatostatin-Positive Neuroendocrine Tumor Model
Carleen Cullinane, Charmaine M Jeffery, Peter D Roselt, et al.
Neuroendocrinology
|
April 14, 2017
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues
Rodney J Hicks, Dik J Kwekkeboom, Eric Krenning, et al.
Journal of Medicinal Chemistry
|
April 7, 2021
A New Turn in Peptide-Based Imaging Agents: Foldamers Afford Improved Theranostics Targeting Cholecystokinin-2 Receptor-Positive Cancer
Alicia Corlett, Marc-Antoine Sani, Jessica Van Zuylekom, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 23, 2016
Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma
Aidan Flynn, Trisha Dwight, Jessica Harris, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 11, 2024
A cutting-edge technology for the future of nuclear medicine
Andor W J M Glaudemans, Adriaan A Lammertsma, Simon R Cherry, et al.
Journal of Medicinal Chemistry
|
August 21, 2009
Discovery of [18F]N-(2-(diethylamino)ethyl)-6-fluoronicotinamide: a melanoma positron emission tomography imaging radiotracer with high tumor to body contrast ratio and rapid renal clearance
Ivan Greguric, Stephen R Taylor, Delphine Denoyer, et al.
Endocrine-Related Cancer
|
May 27, 2025
Peptide receptor radionuclide therapy in malignant insulinoma
David A Pattison, Grace Kong, Timothy Akhurst, et al.
International Journal of Radiation Biology
|
February 24, 2016
Strand breakage by decay of DNA-bound <sup>124</sup>I provides a basis for combined PET imaging and Auger endoradiotherapy
Pavel Lobachevsky, George R Clark, Patrycja D Pytel, et al.
Journal of Neuroendocrinology
|
October 25, 2021
ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
Clarisse Dromain, Marie-Pierre Vullierme, Rodney J Hicks, et al.
Page
of 48
Search research articles
Search
Showing results (381-390 of 471) with videos related to
Sort By:
Page
of 48
European Journal of Nuclear Medicine and Molecular Imaging
|
September 18, 2023
A phase I/II study of the safety and efficacy of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours
Damian Wild, Henning Grønbæk, Shaunak Navalkissoor, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 17, 2020
Peptide Receptor Radionuclide Therapy with <sup>67</sup>Cu-CuSarTATE Is Highly Efficacious Against a Somatostatin-Positive Neuroendocrine Tumor Model
Carleen Cullinane, Charmaine M Jeffery, Peter D Roselt, et al.
Neuroendocrinology
|
April 14, 2017
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues
Rodney J Hicks, Dik J Kwekkeboom, Eric Krenning, et al.
Journal of Medicinal Chemistry
|
April 7, 2021
A New Turn in Peptide-Based Imaging Agents: Foldamers Afford Improved Theranostics Targeting Cholecystokinin-2 Receptor-Positive Cancer
Alicia Corlett, Marc-Antoine Sani, Jessica Van Zuylekom, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 23, 2016
Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma
Aidan Flynn, Trisha Dwight, Jessica Harris, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 11, 2024
A cutting-edge technology for the future of nuclear medicine
Andor W J M Glaudemans, Adriaan A Lammertsma, Simon R Cherry, et al.
Journal of Medicinal Chemistry
|
August 21, 2009
Discovery of [18F]N-(2-(diethylamino)ethyl)-6-fluoronicotinamide: a melanoma positron emission tomography imaging radiotracer with high tumor to body contrast ratio and rapid renal clearance
Ivan Greguric, Stephen R Taylor, Delphine Denoyer, et al.
Endocrine-Related Cancer
|
May 27, 2025
Peptide receptor radionuclide therapy in malignant insulinoma
David A Pattison, Grace Kong, Timothy Akhurst, et al.
International Journal of Radiation Biology
|
February 24, 2016
Strand breakage by decay of DNA-bound <sup>124</sup>I provides a basis for combined PET imaging and Auger endoradiotherapy
Pavel Lobachevsky, George R Clark, Patrycja D Pytel, et al.
Journal of Neuroendocrinology
|
October 25, 2021
ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
Clarisse Dromain, Marie-Pierre Vullierme, Rodney J Hicks, et al.
Page
of 48